Abstract: Gold nanoparticles (AuNPs) have gained increasing
interest in recent times. This is greatly due to their special features,
which include unusual optical and electronic properties, high stability
and biological compatibility, controllable morphology and size
dispersion, and easy surface functionalization. In typical synthesis,
AuNPs were produced by reduction of gold salt AuCl4 in an
appropriate solvent. A stabilizing agent was added to prevent the
particles from aggregating. The antibacterial activity of different
sizes of gold nanoparticles was investigated against Staphylococcus
aureus, Salmonella typhi and Pseudomonas pneumonia using the disk
diffusion method in a Müeller–Hinton Agar. The Au-NPs were
effective against all bacteria tested. That the Au-NPs were
successfully synthesized in suspension and were used to study the
antibacterial activity of the two medicinal plants against some
bacterial pathogens suggests that Au-NPs can be employed as an
effective bacteria inhibitor and may be an effective tool in medical
field. The study clearly showed that the Au-NPs exhibiting inhibition
towards the tested pathogenic bacteria in vitro could have the same
effects in vivo and thus may be useful in the medical field if well
researched into.
Abstract: Studies were carried out to determine the in vitro
susceptibility of the typhoid pathogens to combined action of Euphorbia hirta, Euphorbia heterophylla and Phyllanthus niruri. Clinical isolates of the typhoid bacilli were subjected to susceptibility testing using agar diffusion technique and the minimum inhibitory
concentration (MIC) determined with tube dilution technique. These
isolates, when challenged with doses of the extracts from the three
medicinal plants showed zones of inhibition as wide as 26±0.2mm, 22±0.1mm and 18±0.0mm respectively. The minimum inhibitory concentration (MIC) revealed organisms inhibited at varying
concentrations of extracts: E. hirta (S. typhi 0.250mg/ml, S. paratyphi A 0.125mg/ml, S. paratyphi B 0.185mg/ml and S. paratyphi C 0.225mg/ml), E. heterophylla (S. typhi 0.280mg/ml, S. paratyphi A
0.150mg/ml, S. paratyphi B 0.200mg/ml and S. paratyphi C 0.250mg/ml) and P. niruri (S. typhi 0.150mg/ml, S. paratyphi A 0.100mg/ml, S. paratyphi B 0.115mg/ml and S. paratyphi C 0.125mg/ml). The results of the synergy between the three plants in
the ration of 1:1:1 showed very low MICs for the test pathogens as follows S. typhi 0.025mg/ml, S. paratyphi A 0.080mg/ml, S. paratyphi B 0.015mg/ml and S. paratyphi C 0.10mg/ml with the
diameter zone of inhibition (DZI) ranging from 35±0.2mm,
28±0.4mm, 20±0.1mm and 32±0.3mm respectively. The secondary
metabolites were identified using simple methods and HPLC. Organic components such as anthroquinones, different alkaloids,
tannins, 6-ethoxy-1,2,3,4-tetrahydro-2,2,4-trimethyl and steroids were identified. The prevalence of Salmonellae, a deadly infectious disease, is still very high in parts of Nigeria. The synergistic action of these three plants is very high. It is concluded that pharmaceutical companies should take advantage of these findings to develop new
anti-typhoid drugs from these plants.